Position in NVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$35,063,986
+$8,968,474 QoQ
Shares Held
731,414
+3.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#65
of 1,348 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $2,503,359,774 across 18 Drug Manufacturers - General names. NVO ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
692,569 | $830,688,102 | |
| 2 | JNJ |
Johnson & Johnson
|
1,312,753 | $333,399,877 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,433,801 | $312,743,428 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,946,858 | $245,966,038 | |
| 5 | ABBV |
AbbVie Inc.
|
850,973 | $214,138,842 | |
| 6 | AMGN |
Amgen Inc
|
430,230 | $155,794,886 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,580,079 | $148,664,149 | |
| 8 | AZN |
Astrazeneca PLC
|
447,620 | $84,877,702 |
All Filings in NVO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,063,986 | 731,414 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $26,095,512 | 710,082 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $109,343,204 | 2,149,041 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $52,686,921 | 949,485 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $34,934,196 | 506,146 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $25,244,078 | 363,538 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $63,871,655 | 742,521 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $33,223,863 | 279,028 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $37,310,380 | 261,387 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $57,093,188 | 444,651 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,672,310 | 180,496 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $16,913,021 | 185,980 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $14,304,800 | 88,394 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $12,754,115 | 80,144 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $16,203,987 | 119,728 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $8,575,352 | 86,072 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $9,519,464 | 85,430 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $11,295,006 | 101,711 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $10,154,256 | 90,663 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||